Cargando…
Integration of monitoring aids: A scientific approach for better patient outcome during hyperthermic intraperitoneal chemotherapy
Autores principales: | Gupta, Rakhi, Mittal, Amit Kumar, Choudhary, Manish |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520611/ https://www.ncbi.nlm.nih.gov/pubmed/28781464 http://dx.doi.org/10.4103/0970-9185.209736 |
Ejemplares similares
-
Comment on: hyperthermic intraperitoneal chemotherapy as consolidation treatment of advanced stage ovarian cancer
por: Venkatappa, Shalini, et al.
Publicado: (2022) -
Serum CA-125 and renal impairment in patients undergoing hyperthermic intraperitoneal chemotherapy
por: Bernal-Bello, David, et al.
Publicado: (2022) -
Anesthetic implications in hyperthermic intraperitoneal chemotherapy
por: Gupta, Nishkarsh, et al.
Publicado: (2019) -
Reply: Serum CA-125 and renal impairment in patients undergoing hyperthermic intraperitoneal chemotherapy
por: Chen, Wei-Chun, et al.
Publicado: (2022) -
Severe metabolic acidosis secondary to iatrogenic hyperglycaemia in secondary cytoreduction and hyperthermic intraperitoneal chemotherapy (HiPEC)
por: Sogal, Sachin, et al.
Publicado: (2020)